
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is a strong and reputable company within the visioncare industry, with a diverse portfolio of products that cater to both surgical procedures and vision products. With positive commentary on both the visioncare and surgical segments during its recent earnings call, along with expected growth from products such as Tryptyr, PanOptix Pro, and Precision7, there is potential for Alcon to exceed growth expectations and drive margin expansion. However, there are potential risks to this outlook, such as a weaker economy and delays in product rollouts, that could result in slower than expected growth and margin expansion.
Bears say
Alcon is a leading visioncare company operating in two segments, visioncare and surgical, with a sizable share of the US contact lens market, and a large installed base of eye surgical equipment. The company has seen consistent revenue growth and innovative product launches, with the potential for further growth driven by new products such as ocular health products, contact lenses, and surgical equipment. However, inflationary and tariff pressures may impact operating margins in the short term, and while growth is expected to improve in FY26, risks remain.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares